Hospira, Inc. - FDA 510(k) Cleared Devices

Hospira, Inc. was an American global pharmaceutical and medical device company headquartered in Lake Forest, Illinois. The company specialized in generic injectable pharmaceuticals and integrated infusion therapy systems for hospitals and alternate care settings.

Hospira maintains an FDA 510(k) regulatory record of 44 cleared devices from 45 total submissions between 2004 and 2017. The company's primary focus was General Hospital devices, which comprised the majority of its submissions. Notable cleared products include the Plum 360 Infusion System, extension sets, administration sets, and blood administration products designed for acute-care hospital environments.

Hospira was acquired by Pfizer in September 2015. The medical devices portion was subsequently sold to ICU Medical. This regulatory record represents the company's historical FDA 510(k) clearance activity and should be treated as a historical reference.

Explore the complete list of device names, product codes, and clearance dates in the database to review Hospira's full regulatory submission history.

Regulatory submissions have been managed by Icu Medical, Inc., Underwriters Laboratories, Inc. and Intertek Testing Services.